Compositions containing inhibitors of sodium-glucose cotransporter 1 and sodium-glucose cotransporter 2 and methods of using the inhibitors

摘要

Pharmaceutical dosage forms useful for improving the cardiovascular and/or metabolic health of patients, particularly those suffering from type 2 diabetes, are disclosed, as well as methods of their manufacture.